| Young K Lee, MD | |
|
2100 Westcott Dr, Flemington, NJ 08822 | |
| (908) 788-6407 | |
| (908) 237-2334 |
| Full Name | Young K Lee |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 2100 Westcott Dr, Flemington, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710987961 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MA28903 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Young K Lee, MD Po Box 49, Pittsburgh, PA 15230-0049 Ph: (412) 937-5949 | Young K Lee, MD 2100 Westcott Dr, Flemington, NJ 08822 Ph: (908) 788-6407 |
News Archive
Over the past 30 years, numerous studies have linked Borna disease virus (BDV) with mental illnesses such as bipolar disorder, schizophrenia, anxiety disorder and dementia. Genetic fragments and antibodies to this RNA virus, which causes behavior disorders in a range of mammals and birds, have been found to be prevalent in psychiatric patients, but study results have been inconsistent. Now, the first blinded, case-control study to examine this issue finds no association between the virus and psychiatric illness.
A mom of eight boys, Kim Gudgeon was at her wits' end when she called her family doctor in suburban Chicago to schedule a sick visit for increasingly fussy, 1-year-old Bryce.
The four-year clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease, a degenerative disorder of the central nervous system.
Asuragen, Inc. and Life Technologies Corporation announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). Asuragen manufacturers the monitoring test, which is exclusively distributed by Life Technologies and runs on the company's Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument™.
In a recent article published in MELANOMA RESEARCH and a subsequent commentary in British medical journal THE LANCET, researchers at Moffitt Cancer Center discussed new therapeutic options for the management of melanoma brain metastases. Patients with advanced melanoma are at high risk for developing brain metastases. Once brain metastases are present, these patients tend to have poor outcomes.
› Verified 6 days ago
Maureen E Basius, DO Pathology Medicare: Medicare Enrolled Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-788-6407 Fax: 908-237-2334 | |
Gina Marie Zanchelli-astran, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-788-6100 | |
Steven M Diamond, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2100 Westcott Dr, Flemington, NJ 08822 Phone: 908-788-6407 Fax: 908-237-2334 |